Abbvie (ABBV) PT Lowered to $80 at Piper Jaffray
Tweet
Share
E-mail
Get Alerts ABBV Hot Sheet
Price: $248.78 -2.99%
Rating Summary:
28 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 26 | Down: 25 | New: 65
Rating Summary:
28 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 26 | Down: 25 | New: 65
Join SI Premium – FREE
Piper Jaffray analyst Christopher Raymond lowered the price target on Abbvie (NYSE: ABBV) to $80.00 (from $90.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Abbvie (ABBV) PT Raised to $282 at BofA Securities
- Quest Diagnostics (DGX) PT Raised to $245 at UBS
- Roivant Sciences (ROIV) PT Raised to $55 at Piper Sandler
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
